申请人:Galileo Pharmaceuticals, Inc.
公开号:US06653346B1
公开(公告)日:2003-11-25
Cytoprotective compounds, many of which are benzofuran derivatives are useful in the treatment of certain ischemic or inflammatory conditions, including but not limited to stroke, myocardial infarction, congestive heart failure, and skin disorders characterized by inflammation or oxidative damage. They are also useful in the manufacture of pharmaceutical and cosmetic formulations for the treatment of such conditions.
细胞保护化合物,其中许多是苯并呋喃衍生物,在治疗某些缺血或炎症状况中非常有用,包括但不限于中风、心肌梗死、充血性心力衰竭和表皮疾病,其特征为炎症或氧化损伤。它们也可用于制造用于治疗此类病症的制药和化妆品配方。